These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020 [TBL] [Abstract][Full Text] [Related]
23. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Park SH; Sung JH; Chung N Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532 [TBL] [Abstract][Full Text] [Related]
25. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
26. Gemcitabine Enhances Kras-MEK-Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating Cells. Shimizu K; Nishiyama T; Hori Y Pancreas; 2017 Feb; 46(2):268-275. PubMed ID: 28060183 [TBL] [Abstract][Full Text] [Related]
27. PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Li W; Zhu Y; Zhang K; Yu X; Lin H; Wu W; Peng Y; Sun J Exp Mol Med; 2020 Mar; 52(3):409-422. PubMed ID: 32123287 [TBL] [Abstract][Full Text] [Related]
28. FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. Hou J; Wang L PLoS One; 2012; 7(5):e36252. PubMed ID: 22590527 [TBL] [Abstract][Full Text] [Related]
29. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. Yao J; Cai HH; Wei JS; An Y; Ji ZL; Lu ZP; Wu JL; Chen P; Jiang KR; Dai CC; Qian ZY; Xu ZK; Miao Y Oncol Rep; 2010 May; 23(5):1375-82. PubMed ID: 20372854 [TBL] [Abstract][Full Text] [Related]
30. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. Ganguly K; Bhatia R; Rauth S; Kisling A; Atri P; Thompson C; Vengoji R; Ram Krishn S; Shinde D; Thomas V; Kaur S; Mallya K; Cox JL; Kumar S; Batra SK Gastroenterology; 2022 Jan; 162(1):253-268.e13. PubMed ID: 34534538 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronic Acid-Based Multilayer Films Regulate Hypoxic Multicellular Aggregation of Pancreatic Cancer Cells with Distinct Cancer Stem-Cell-like Properties. Lee IC; Wu YC; Hung WS ACS Appl Mater Interfaces; 2018 Nov; 10(45):38769-38779. PubMed ID: 30395429 [TBL] [Abstract][Full Text] [Related]
32. Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1. Wang Q; Gong M; Liu R; Mo J; Bai R; An R; Wang X; Han L; Wang Z; Ma Q; Wu Z; Zhou C Phytomedicine; 2024 Jul; 129():155656. PubMed ID: 38723529 [TBL] [Abstract][Full Text] [Related]
33. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984 [TBL] [Abstract][Full Text] [Related]
34. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681 [TBL] [Abstract][Full Text] [Related]
35. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
36. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. Kato H; Seto K; Kobayashi N; Yoshinaga K; Meyer T; Takei M Life Sci; 2011 Oct; 89(17-18):603-8. PubMed ID: 21839751 [TBL] [Abstract][Full Text] [Related]
37. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine. Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084 [TBL] [Abstract][Full Text] [Related]
38. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling. Yang D; Tang Y; Fu H; Xu J; Hu Z; Zhang Y; Cai Q Biochem Biophys Res Commun; 2018 Oct; 505(1):215-221. PubMed ID: 30243721 [TBL] [Abstract][Full Text] [Related]
39. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Du Z; Qin R; Wei C; Wang M; Shi C; Tian R; Peng C Dig Dis Sci; 2011 Mar; 56(3):741-50. PubMed ID: 20683663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]